C
ROIV icon

Covestor’s Roivant Sciences ROIV Stock Holding History

Covestor’s Portfolio ROIV Stock Details ROIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$65K Sell
1,850
-269
-13% -$7.95K 0.04% 637
2026
Q1 		$59K Sell
2,119
-186
-8% -$4.78K 0.04% 603
2025
Q4 		$50K Sell
2,305
-298
-11% -$5.88K 0.03% 909
2025
Q3 		$39K Sell
2,603
-14
-0.5% -$173 0.02% 1024
2025
Q2 		$30K Sell
2,617
-31,558
-92% -$342K 0.02% 1101
2025
Q1 		$345K Buy
34,175
+13,541
+66% +$146K 0.23% 40
2024
Q4 		$245K Buy
20,634
+1,444
+8% +$17.1K 0.15% 99
2024
Q3 		$222K Buy
19,190
+1,605
+9% +$18.3K 0.14% 141
2024
Q2 		$186K Sell
17,585
-7,593
-30% -$83.2K 0.12% 180
2024
Q1 		$265K Buy
25,178
+4,684
+23% +$50.5K 0.17% 74
2023
Q4 		$230K Buy
20,494
+12,237
+148% +$119K 0.16% 99
2023
Q3 		$96K Buy
8,257
+8,252
+165,040% +$93.3K 0.07% 442
2023
Q2 		$0 Buy
+5
New +$45 ﹤0.01% 2565

Other funds holding ROIV

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
QF
QVT Financial New York $1.7B AUM 173.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

Covestor's ROIV Position: Q2 2026 in Review

Covestor reduced its Roivant Sciences (ROIV) stake by 13% in Q2 2026, selling an estimated $7.95K and leaving 1,850 shares worth $65K. The position accounts for 0.04% of the portfolio, ranked #637.

Covestor first reported a position in ROIV in Q2 2023 and has held it in 13 quarters since. The position peaked at $345K in Q1 2025. 498 funds tracked by Wall St. Rank hold ROIV as of Q2 2026.

  • Covestor held 1,850 shares of Roivant Sciences worth $65K as of Q2 2026.
  • Covestor sold 269 Roivant Sciences shares in Q2 2026, an estimated $7.95K.
  • Roivant Sciences made up 0.04% of Covestor's portfolio in Q2 2026, its #637 holding.
  • Covestor first reported a position in Roivant Sciences in Q2 2023 and has held it in 13 quarters since.
  • Covestor's Roivant Sciences position peaked at $345K in Q1 2025.
  • 498 funds tracked by Wall St. Rank held Roivant Sciences as of Q2 2026.

Based on Covestor's 13F filing for Q2 2026, filed 7 Aug 2026.